Results of data mining transcriptomes and clinical files from a large cohort of GBM samples revealed that the cumulative survival was higher in GBM patients with a high number of tumor-infiltrating CD8+ T cells and ITGAE (CD103) and CD69 positive cells. The gene discussed is CD8A; the disease is glioblastoma.